| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/05/1999 | US5856130 Human pathogenesis-related protein |
| 01/05/1999 | US5856129 Hydridized detector |
| 01/05/1999 | US5856128 Human nucleic acid binding protein |
| 01/05/1999 | US5856126 Peptide having anti-thrombus activity and method of producing the same |
| 01/05/1999 | US5856125 ETS2 repressor factor (ERF) genetic locus and its products |
| 01/05/1999 | US5856124 DNA encoding high-affinity melatonin receptors |
| 01/05/1999 | US5856121 Nucleotide sequence |
| 01/05/1999 | US5856110 Heregulin |
| 01/05/1999 | US5856109 Homolog of rat elastase IV derived from human pancreas |
| 01/05/1999 | US5856106 Immune response to a glycoprotein |
| 01/05/1999 | US5856099 Hybridization; nucleoside oligomers |
| 01/05/1999 | US5856098 Detection of this receptor variant in cells of obese individuals, and methods for treating obesity by targeting variant. |
| 01/05/1999 | US5856094 Novel cell cycle regulatory polynucleotides |
| 01/05/1999 | US5856091 Isolated nucleic acid sequence coding for a tumor rejection antigen precursor processed to at least one tumor rejection antigen presented by HLA-A2 |
| 01/05/1999 | US5855987 Bioactive conjugates of cellulose with amino compounds |
| 01/05/1999 | US5855920 Total hormone replacement therapy |
| 01/05/1999 | US5855919 Method using keyhole limpet hemocyanin composition with enhanced immunogenic activity |
| 01/05/1999 | US5855918 Cystic fibrosis therapy |
| 01/05/1999 | US5855913 Particles incorporating surfactants for pulmonary drug delivery |
| 01/05/1999 | US5855911 Liposomal phosphodiester, phosphorothioate, and P-ethoxy oligonucleotides |
| 01/05/1999 | US5855907 Method of treatment of migraine |
| 01/05/1999 | US5855900 Supramolecular-structured biodegradable polymeric assembly for drug delivery |
| 01/05/1999 | US5855892 Administering daidzein |
| 01/05/1999 | US5855889 Polypeptide antibody |
| 01/05/1999 | US5855888 Monoclonal antibody which recognizes specifically extracellular region of human vla-2, .alpha. chain. the above drug for the treatment can suppress swelling with low toxicity |
| 01/05/1999 | US5855887 Lymphocyte activation in response to antigen |
| 01/05/1999 | US5855884 Administering an antibody, a corticotropin releasing hormone inhibitor to treat stress related migraine or headache |
| 01/05/1999 | US5855883 Method of disinsertion of vitreous body from neural retina of the eye with Proteus vulgaris chondroitinases I and II |
| 01/05/1999 | US5855882 Methods for inhibiting the cross-linking of advanced glycosylation endproducts |
| 01/05/1999 | US5855881 Mammalian alcohol dehydrogenase and aldehyde dehydrogenase production in plants |
| 01/05/1999 | US5855866 Constructs designed to have a cytotoxic or otherwise anticellular effect against tumor vasculature |
| 01/05/1999 | CA2105788C Enteral nutritional product |
| 01/05/1999 | CA2084891C Methods and formulations for use in inhibiting conception and in treating benign gynecological disorders |
| 01/05/1999 | CA2078373C Peptides for the production of preparations for the diagnosis and therapy of systemic lupus |
| 01/03/1999 | CA2236462A1 Murc |
| 01/02/1999 | CA2221861A1 Ynl075w/htxft19 |
| 01/01/1999 | CA2236459A1 Novel compounds |
| 01/01/1999 | CA2236452A1 Gida1 |
| 01/01/1999 | CA2236441A1 Gida2 |
| 01/01/1999 | CA2236435A1 Gida2 |
| 01/01/1999 | CA2236431A1 Gidb |
| 01/01/1999 | CA2236425A1 Gida1 |
| 01/01/1999 | CA2235785A1 Serine/threonine protein kinase (h-sgk2) |
| 12/30/1998 | WO1998059071A1 Lyme disease vaccines |
| 12/30/1998 | WO1998059064A1 Complexes for transporting nucleic acid into eukaryotic higher-cells |
| 12/30/1998 | WO1998059063A2 Bovine adenovirus type 3 genome |
| 12/30/1998 | WO1998059055A2 Detoxifying proteins |
| 12/30/1998 | WO1998059053A1 Immonogenic fragments of toxin a of clostridium difficile |
| 12/30/1998 | WO1998059047A1 Monoclonal antibody specific to anti-human fibrin monomer, process for producing the same, hybridomas, and immunoassay method |
| 12/30/1998 | WO1998059045A1 Preparation of protein hydrolysates |
| 12/30/1998 | WO1998059041A2 Disease related nucleotide kinases |
| 12/30/1998 | WO1998059040A2 Human catalytic telomerase sub-unit and its diagnostic and therapeutic use |
| 12/30/1998 | WO1998059039A1 Receptor kinase, bin1 |
| 12/30/1998 | WO1998059034A2 Treponema pallidum polynucleotides and sequences |
| 12/30/1998 | WO1998058965A2 B7-binding molecules for treating immune diseases |
| 12/30/1998 | WO1998058964A1 Methods and compositions for galactosylated glycoproteins |
| 12/30/1998 | WO1998058962A1 Prolactin secretion modulator |
| 12/30/1998 | WO1998058960A1 PEPTIDES DERIVED FROM COMPLEMENT PEPTIDE C3a SEQUENCE AND ANTIALLERGIC COMPOSITIONS COMPRISING THEM |
| 12/30/1998 | WO1998058958A2 Human jagged polypeptide, encoding nucleic acids and methods of use |
| 12/30/1998 | WO1998058957A2 Disulfide cross-linked glycoprotein hormone analogs, their preparation and use |
| 12/30/1998 | WO1998058955A2 Nuclear matrix targeting peptides and uses therefor |
| 12/30/1998 | WO1998058954A2 Sperm specific antigens 4.1 and 6.7, dna encoding them and contraceptive vaccines comprising said sperm antigens |
| 12/30/1998 | WO1998058953A2 Surface exposed proteins from chlamydia pneumoniae |
| 12/30/1998 | WO1998058952A1 Angiotensin derivatives |
| 12/30/1998 | WO1998058950A1 Compounds with growth hormone releasing properties |
| 12/30/1998 | WO1998058949A1 Treatment of insulin resistance with growth hormone secretagogues |
| 12/30/1998 | WO1998058948A1 Tartrate salt of a substituted dipeptide as growth hormone secretagogue |
| 12/30/1998 | WO1998058947A1 Dipeptide derivatives as growth hormone secretagogues |
| 12/30/1998 | WO1998058943A1 Borrelia burgdorferi polynucleotides and sequences |
| 12/30/1998 | WO1998058678A1 Anti-cd40l immunotoxins for the treatment of diseases |
| 12/30/1998 | WO1998058674A1 Anti-tumour pharmaceutical compositions capable of reducing drug resistance in tumour cells |
| 12/30/1998 | WO1998058672A1 Cd154 blockade therapy for therapeutic protein inhibitor syndrome |
| 12/30/1998 | WO1998058671A1 Topical treatment of psoriasis using neutralizing antibodies to il-8 |
| 12/30/1998 | WO1998058669A2 Cd154 blockade therapy for pancreatic islet tissue transplantation |
| 12/30/1998 | WO1998058667A1 Use of at least one proteolytic enzyme for treating glomerulonephritis |
| 12/30/1998 | WO1998058666A1 Use of proteolytic enzymes for treating uveitis |
| 12/30/1998 | WO1998058665A1 Use of proteolytic enzymes for preventing or treating graft rejection |
| 12/30/1998 | WO1998058664A1 Use of proteolytic enzymes for treating septic shock |
| 12/30/1998 | WO1998058663A1 Use of proteolytic enzymes for influencing cytokines |
| 12/30/1998 | WO1998058662A1 Induction of tolerance by proteases |
| 12/30/1998 | WO1998058661A1 Use of fviia for the treatment of bleedings in patients with a normal blood clotting cascade and normal platelet function |
| 12/30/1998 | WO1998058660A1 Pharmaceutical combination preparations containing erythropoietin and modified haemoglobins |
| 12/30/1998 | WO1998058659A1 Pharmaceutical compound preparation comprising a parathyroid hormone preparation an a calcium/phosphate preparation |
| 12/30/1998 | WO1998058658A1 Therapeutic method for management of diabetes mellitus |
| 12/30/1998 | WO1998058657A1 Gonadotropin releasing hormone antagonist |
| 12/30/1998 | WO1998058653A1 Methods for the inhibition of neuronal activity by local delivery of adenosine |
| 12/30/1998 | WO1998058635A2 Method for the treatment of cancer with exochelins of mycobacterium tuberculosis |
| 12/30/1998 | WO1998058633A2 Microdose therapy of vascular conditions by no donors |
| 12/30/1998 | WO1998058629A2 Preparation of pharmaceutical compositions |
| 12/30/1998 | WO1998058541A1 Modulation of apoptosis |
| 12/30/1998 | WO1998044115A3 Regulators of g-protein signalling |
| 12/30/1998 | WO1998040404A3 Secreted proteins and polynucleotides encoding them |
| 12/30/1998 | EP0887416A2 Human AFC1 |
| 12/30/1998 | EP0887415A2 Human RCE1 |
| 12/30/1998 | EP0887414A2 Human serine proteases HGBAB90 |
| 12/30/1998 | EP0887413A2 Histidine kinase |
| 12/30/1998 | EP0887411A2 N-acetylglucosamine-1-phosphate uridyltransferase (GlmU) from Streptococcus pneumoniae |
| 12/30/1998 | EP0887408A1 Wnt-3 oncogene: polypeptides and polynucleotides |
| 12/30/1998 | EP0887407A2 cDNA clone HAPO167 that encodes a human 7-transmembrane receptor |
| 12/30/1998 | EP0887406A2 A member of the FRZB family, franzzled |